PfATP4 screening - A pH-based 'fingerprint' screen to simultaneously identify inhibitors of multiple validated and potential antimalarial drug targets
Researchers
- Dr Adele Lehane (Primary Investigator)
- Dr Amee George (Secondary Investigator)
Grant status
Completed-Pending ReportsGrant start date
01/09/2019Grant funding
- 2019: $55,021 from Medicines for Malaria Venture
- 2020: $61,086 from Medicines for Malaria Venture
- 2021: $61,086 from Medicines for Malaria Venture
